180 related articles for article (PubMed ID: 28342204)
1. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
Li X; Yang B; Han G; Li W
J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
[TBL] [Abstract][Full Text] [Related]
2. Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240.
Hoshikawa H; Goto R; Mori T; Mitani T; Mori N
Int J Oncol; 2009 Mar; 34(3):847-52. PubMed ID: 19212690
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
4. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
[TBL] [Abstract][Full Text] [Related]
6. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
Fan Y; Wang Y; Wang K
Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PGE
Huang H; Aladelokun O; Ideta T; Giardina C; Ellis LM; Rosenberg DW
Sci Rep; 2019 Mar; 9(1):4954. PubMed ID: 30894570
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions.
Yamamoto E; Izawa T; Juniantito V; Kuwamura M; Sugiura K; Takeuchi T; Yamate J
Histol Histopathol; 2010 Aug; 25(8):995-1007. PubMed ID: 20552550
[TBL] [Abstract][Full Text] [Related]
13. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells.
Prijatelj M; Celhar T; Mlinaric-Rascan I
Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):19-26. PubMed ID: 21600299
[TBL] [Abstract][Full Text] [Related]
16. Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice.
Li N; Zhang L; An Y; Zhang L; Song Y; Wang Y; Tang H
J Proteome Res; 2015 Mar; 14(3):1566-73. PubMed ID: 25669961
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor.
Aoudjit L; Potapov A; Takano T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1534-42. PubMed ID: 16396944
[TBL] [Abstract][Full Text] [Related]
19. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study.
Dolkart O; Liron T; Chechik O; Somjen D; Brosh T; Maman E; Gabet Y
Am J Sports Med; 2014 Dec; 42(12):2869-76. PubMed ID: 25184246
[TBL] [Abstract][Full Text] [Related]
20. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
